MXPA03011199A - Derivados de pirazol como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana (vih). - Google Patents

Derivados de pirazol como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana (vih).

Info

Publication number
MXPA03011199A
MXPA03011199A MXPA03011199A MXPA03011199A MXPA03011199A MX PA03011199 A MXPA03011199 A MX PA03011199A MX PA03011199 A MXPA03011199 A MX PA03011199A MX PA03011199 A MXPA03011199 A MX PA03011199A MX PA03011199 A MXPA03011199 A MX PA03011199A
Authority
MX
Mexico
Prior art keywords
compounds
reverse transcriptase
pyrazole derivatives
formula
transcriptase inhibitors
Prior art date
Application number
MXPA03011199A
Other languages
English (en)
Spanish (es)
Inventor
Stephen Jones Philip
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MXPA03011199A publication Critical patent/MXPA03011199A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
MXPA03011199A 2001-06-04 2002-05-29 Derivados de pirazol como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana (vih). MXPA03011199A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0113524.3A GB0113524D0 (en) 2001-06-04 2001-06-04 Pyrazole derivatives
PCT/EP2002/005898 WO2002100853A1 (en) 2001-06-04 2002-05-29 Pyrazole derivatives as hiv reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
MXPA03011199A true MXPA03011199A (es) 2004-02-26

Family

ID=9915841

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03011199A MXPA03011199A (es) 2001-06-04 2002-05-29 Derivados de pirazol como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana (vih).

Country Status (17)

Country Link
US (1) US6538015B1 (enExample)
EP (1) EP1401826B1 (enExample)
JP (1) JP4088249B2 (enExample)
KR (1) KR100627532B1 (enExample)
CN (1) CN1249052C (enExample)
AT (1) ATE357439T1 (enExample)
AU (1) AU2002325221B2 (enExample)
BR (1) BR0210158A (enExample)
CA (1) CA2448058C (enExample)
DE (1) DE60219009T2 (enExample)
DK (1) DK1401826T3 (enExample)
ES (1) ES2282446T3 (enExample)
GB (1) GB0113524D0 (enExample)
MX (1) MXPA03011199A (enExample)
PT (1) PT1401826E (enExample)
WO (1) WO2002100853A1 (enExample)
ZA (1) ZA200308781B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
JP4993407B2 (ja) 2004-08-04 2012-08-08 大正製薬株式会社 トリアゾール誘導体
WO2006072833A1 (en) * 2005-01-06 2006-07-13 Pfizer Limited Imidazole derivatives as enzyme reverse transcriptase modulators
EP1988083B1 (en) 2006-02-03 2014-04-02 Taisho Pharmaceutical Co., Ltd. Triazole derivative
RU2395499C2 (ru) * 2006-02-06 2010-07-27 Тайсо Фармасьютикал Ко., Лтд. Ингибитор связывания сфингозин-1-фосфата
PL2057125T3 (pl) 2006-08-16 2011-09-30 Hoffmann La Roche Nienukleozydowe inhibitory odwrotnej transkryptazy
BRPI0813404A2 (pt) 2007-06-22 2014-12-30 Hoffmann La Roche Derivados de uréia e carbamato como inibidores de transcriptase reversa de não-nucleosídeo
SI2177512T1 (sl) 2007-08-01 2012-06-29 Taisho Pharmaceutical Co Ltd Inhibitor vezave S1P1
RU2495878C2 (ru) 2007-12-21 2013-10-20 Ф.Хоффманн-Ля Рош Аг Гетероциклические антивирусные соединения
DE102008015032A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008015033A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
EP2295038B1 (en) * 2009-09-11 2013-05-29 AiCuris GmbH & Co. KG Solid dispersion comprising an anti-HIV agent
ES2528646T3 (es) * 2010-05-20 2015-02-11 Bayer Intellectual Property Gmbh Procedimiento para la fabricación de 1-alquil-3-difluorometil-5-hidroxipirazoles
JP5722891B2 (ja) 2010-07-15 2015-05-27 大日本住友製薬株式会社 ピラゾール化合物
WO2014074628A1 (en) * 2012-11-08 2014-05-15 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Compounds for treating hiv and methods for using the compounds
US9925190B2 (en) 2015-02-16 2018-03-27 University of Pittsburgh—of the Commonwealth System of Higher Education Small molecules targeting HIV-1 Nef

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0627423A4 (en) 1992-01-22 1995-02-15 Nissan Chemical Ind Ltd SUBSTITUTED PYRAZOLE DERIVATIVES AND BACTERICIDES FOR AGRICULTURE AND GARDENING.
US6005109A (en) 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
DK0786455T3 (da) 1994-09-26 2004-03-29 Shionogi & Co Imidazolderivater
US5698495A (en) 1995-11-15 1997-12-16 Zeneca Limited Herbicidal substituted pyrazole compounds
GB0016787D0 (en) 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy
GB0024795D0 (en) 2000-10-10 2000-11-22 Hoffmann La Roche Pyrazole derivatives for the treatment of viral diseases

Also Published As

Publication number Publication date
PT1401826E (pt) 2007-06-19
AU2002325221B2 (en) 2008-07-31
JP4088249B2 (ja) 2008-05-21
CN1527829A (zh) 2004-09-08
WO2002100853A1 (en) 2002-12-19
CN1249052C (zh) 2006-04-05
US6538015B1 (en) 2003-03-25
DE60219009T2 (de) 2007-12-13
EP1401826A1 (en) 2004-03-31
ATE357439T1 (de) 2007-04-15
JP2004532276A (ja) 2004-10-21
ZA200308781B (en) 2005-02-11
CA2448058C (en) 2008-12-23
GB0113524D0 (en) 2001-07-25
CA2448058A1 (en) 2002-12-19
DK1401826T3 (da) 2007-07-30
EP1401826B1 (en) 2007-03-21
BR0210158A (pt) 2004-06-08
DE60219009D1 (de) 2007-05-03
KR20040003050A (ko) 2004-01-07
KR100627532B1 (ko) 2006-09-21
ES2282446T3 (es) 2007-10-16

Similar Documents

Publication Publication Date Title
YU27203A (sh) Pirazol derivati za tretiranje virusnih oboljenja
MXPA03011199A (es) Derivados de pirazol como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana (vih).
TW200512208A (en) Piperazine derivatives
MY128463A (en) 4' substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
MXPA03005464A (es) Agentes antivirales.
MY146669A (en) Pyrazole derivatives for treating hiv
JO2403B1 (en) Nickeloside derivatives antiviral
MY139506A (en) Hiv replication inhibitors
GEP20053601B (en) Nucleoside Derivatives as Inhibitors of RNA-Dependent RNA Viral Polymerase
MXPA03011192A (es) Nucleosidos 4'-substituidos.
CA2445744A1 (en) Antiviral nucleoside derivatives
WO2004071426A3 (en) Compounds for the treatment of viral infection
TW200621762A (en) Novel compounds
MXPA02012409A (es) Derivados de pirrol para tratamiento del sida.
CA2437785A1 (en) Hiv inhibiting pyrazinone derivatives
DE60318874D1 (en) Pyrazolderivate
HUP0204001A2 (hu) Helyettesített amino-metil-fenil-ciklohexán-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
TW200616635A (en) Novel compounds
HUP0203161A2 (hu) Benzamidinszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AU2003263455A1 (en) Pyrazole amides for treating hiv infections
BR0115476A (pt) Derivados de imidazolona para o tratamento de doenças virais
MY201070A (en) Novel triterpene derivatives as hiv inhibitors
EA200500287A1 (ru) Производные 4-(3, 5-дицианофенокси)пиразола для применения в качестве модуляторов обратной транскриптазы в лечении, в числе прочего, вич-инфекции
AU2003264940A1 (en) Pyrazole derivatives and their use as therapeutic agents for hiv mediated diseases
AU4485101A (en) Antiviral therapy

Legal Events

Date Code Title Description
FG Grant or registration